Johnson & Johnson

Johnson & Johnson files marketing application in Europe for expanded use for multiple myeloma med Darzalex

Johnson & Johnson (JNJ +0.6%) unit Janssen-Cilag International NV files a Type II variation application with the European Medicines Agency seeking …

Business

Johnson & Johnson: Dividend King With Good Total Return And Dividend Growth

Johnson & Johnson total return over-performed the DOW average for my 58.0 month test period by 33.72%, which is great.<p>Johnson & Johnson Has increased …

Stocks

Expanded use of Johnson & Johnson's prostate cancer med Zytiga OK'd in Europe

The European Commission approves the use of Johnson & Johnson's (NYSE:JNJ) ZYTIGA (abiraterone acetate), in combination with hormone deprivation …

Business

Tax reform is vital for our competitiveness around the globe | Opinion

<b>By Dominic J. Caruso</b><p>As a New Jersey-based company that employs 9,000 workers across the state, Johnson & Johnson commends our leaders in the U.S. …

New Brunswick

Johnson & Johnson wins California lawsuit claiming asbestos in talc caused cancer

(Reuters) - A California jury on Thursday ruled in favor of Johnson & Johnson (NYSE:JNJ) in a lawsuit by a woman who said she developed the cancer …

Stock Markets

Achillion Heel: Stock Plunges as J&J Exits

It was just two months ago when shares of <b>Achillion Pharmaceuticals</b> (ACHN) were crushed by news that its all-important hepatitis C partnership with</b> …

Pharma

Deutsch New York Hires Its New Chief Strategy Officer Away From JWT

The New York office of Deutsch has hired Matt Baker away from WPP’s J. Walter Thompson, naming him chief strategy officer, a position that has been …

Advertising

Why Achillion Pharmaceuticals Stock Is Falling Today

Johnson & Johnson reportedly plans to dump its entire stake in Achillion Pharmaceuticals through a public offering.<p>What happened<p>Shares of <b>Achillion</b> …

Stocks

3 Indisputable Reasons Why AbbVie Is the Best Big Pharma Stock

What's the best big pharma stock?<p>Of course, "best" can mean different things to different people. But with stocks, there are key metrics that can be used to determine which are better than others. And if one stock clearly dominates in several of those metrics, it has a strong argument in being …

Stocks

Johnson & Johnson: Does This Dividend Giant Still Offer Value?

Year-to-date JNJ is up over 20% with no signs of slowing down.<p>JNJ has been a staple in many dividend investors portfolio for many years now, but EPS …

Stocks

Genmab earns $25M milestone from Janssen's first Darzalex sale in Japan

Johnson & Johnson (JNJ -0.1%) unit Janssen Biotech has booked the first commercial sale of multiple myeloma med DARZALEX (daratumumab) in Japan, …

Business

Achillion readies sale of 18.4M-share J&J stake; shares down 9% after hours

Achillion Pharmaceuticals (NASDAQ:ACHN) announces plans to sell 18,367,346 common shares currently owned by Johnson & Johnson Innovation-JJDC …

Business

Who Might Acquire Colgate-Palmolive?

CL rallied 3% on Wednesday on rumors that it was about to be acquired.<p>Similar rumors boosted the stock in May and in a few other occasions in the …

Stocks

Colgate-Palmolive Settles Claims Over Asbestos in Talcum Powder

Colgate-Palmolive Co. agreed to settle a lawsuit claiming its talcum-powder products caused a Pennsylvania woman to develop mesothelioma, a fatal …

Business

Sale/IPO of Ortho-Clinical Diagnostics?

Carlyle Group (NASDAQ:CG) is exploring a sale or IPO of Ortho-Clinical Diagnostics that could be valued at more than $7B, including debt, Reuters …

Business

FDA OKs expanded use for Bristol-Myers' Sprycel

Under Priority Review status, the FDA approves Bristol-Myers Squibb's (NYSE:BMY) Sprycel (dasatinib) tablets for the treatment of pediatric patients …

Business

Johnson & Johnson CEO reveals the leadership lessons he learned at West Point

Johnson & Johnson Chairman and CEO Alex Gorsky says being a successful leader all comes down to the valuable lessons he learned as a cadet at the …

Leadership

Johnson & Johnson CEO: Washington needs to work with us for 'smart tax policy'

Jim Cramer spoke to Johnson & Johnson Chairman and CEO Alex Gorsky about the role of government and employing veterans.

Taxes

Carlyle explores sale or IPO of Ortho-Clinical Diagnostics - sources

Private equity firm Carlyle Group is exploring a sale or initial public offering of Ortho-Clinical Diagnostics Inc, a U.S. diagnostics company that could be valued at more than $7 billion, including debt, people familiar with the matter said.<p>A divestment of Ortho-Clinical Diagnostics, which Carlyle …

Business

Victory Comes From Leadership: Cramer's 'Mad Money' Recap (Thursday 11/9/17)

Companies with leadership are the ones who prevail in this market, Jim Cramer told a live audience of <i>Mad Money</i> viewers Thursday, as he celebrated …

Stocks

Impax Lab beats by $0.03, misses on revenue

Impax Lab (NASDAQ:IPXL): Q3 EPS of $0.23 beats by $0.03.<p>Revenue of $206.39M (-9.4% Y/Y) misses by $3.22M.<p>Press Release<p>Now read: <b>Johnson & Johnson</b> …

Business

DIGITAL HEALTH BRIEFING: Johnson & Johnson introduces healthcare platform — NIH will give out 10,000 Fitbit devices — Hasbro, Brown develop robotic companions

<i>Welcome to Digital Health Briefing, a new morning email providing the latest news, data, and insight on how digital technology is disrupting the healthcare ecosystem, produced by BI Intelligence.</i><p><b>Sign up and receive Digital Health Briefing free to your inbox.</b><p><i>Have feedback? We'd like to hear from</i> …

Medical Technology

Cardiff-Based Orchard Media and Events Group Makes a Move in London

The Cardiff-based Orchard Media and Events Group has London in its sights with the appointment of new Client Relationship Manager Ali Morrill to its …

News (Wales)

Johnson & Johnson to advance Tremfya into Phase 3 for psoriatic arthritis

Longer-term results from a Phase 2 clinical trial evaluating Johnson & Johnson's (NYSE:JNJ) TREMFYA (guselkumab) for the treatment of active …

Business

Johnson & Johnson to Produce Surgical Devices in Suzhou Factory

American health care giant Johnson & Johnson has recently broken ground on a $180-million medical device plant in China, facing up to the rising …

News (China)

Johnson & Johnson's Stelara successful in mid-stage lupus study

Johnson & Johnson (NYSE:JNJ) unit Janssen Research & Development LLC announces positive results from a Phase 2 clinical trial assessing STELARA …

Business

Merck: A Slow And Steady Dividend Grower, But Do Better Alternatives Exist?

<i>Originally published on October 31, 2017</i><p>Blue chip drug makers such as Merck (NYSE:MRK) have historically been very popular with income investors …

Stocks

Which Stocks Have Top Fund Managers Been Buying – And Selling?

Over the last three months, the top-performing mutual funds have continued to pick up shares in chip stocks like <b>Applied Materials</b> (AMAT) and <b>Intel</b> …

Stocks

What To Hold If You're Afraid Of An Upcoming Bear Market

Bear markets cause traumatic experiences to investors.<p>Too many investors have missed the exceptional bull market due to their fear of an imminent …

Stocks

Google's grand plan for health, from fitness apps right up to defeating death

Verily, DeepMind, and Calico are all part of Google's long game for the future for the company.<p><i>Video: Apple takes on healthcare from patient to</i> …

Digital Health